Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
21 July 2020 | Story Nitha Ramnath | Photo UFS photo archive

The Department of Business Management within the Faculty of Economic and Management Sciences is one of four successful recipients of the Nurturing Emerging Scholars Programme (NESP), which aims to recruit honours graduates who demonstrate academic ability and express an early interest in the possibility of an academic career. 

 “The NESP is a mechanism that addresses a potential shortcoming in the department in the medium to long term. Most of the academics in the department specialise either in entrepreneurship or marketing. As such, the availability of academics with interdisciplinary business knowledge who can teach and do research across the different sub-fields of business management is limited,” says Prof Brownhilder Neneh, Associate Professor in the Department of Business Management.

Once graduates enter the programme – as NESP master’s graduates they form part of a resource pool from which new academics can be recruited. 

Prof Neneh continues: “Considering the imminent retirement of academics in the department, the NESP provides an opportunity to recruit an academic who is able to work with experienced academics, gain experience, and ‘prepare’ the person to become an expert across the different fields in the department.”

“This programme would assist in succession planning within the department as well as training individuals within academia,” she says. 

According to Prof Neneh, access to this funding opportunity will further strengthen and expand the path that the department has embarked upon as far as striving for excellence in teaching, research, and community engagement is concerned, thereby contributing to address key societal challenges. “Appointing an NESP candidate would be an ideal opportunity to recruit an academic who will be able to work with the senior staff and gain experience and teaching/research competencies relevant to the 4IR, and ‘prepare’ the person to become the business management expert in the department,” she says.

News Archive

Haemophilia home infusion workshop
2017-12-17


 Description: haemophilia Tags: Haemophilia, community, patient, clinical skills, training 

Parents receive training for homecare of their children with haemophilia.
Photo Supplied


Caregivers for haemophilia patients, and patients themselves from around the Free State and Northern Cape attended a home infusion workshop held by the Clinical Skills unit in the Faculty of Health Sciences in July 2017. “It felt liberating and I feel confident to give the factor to my son correctly,” said Amanda Chaba-Okeke, the mother of a young patient, at the workshop. Her son, also at the workshop, agreed. “It felt lovely and good to learn how to administer factor VIII.” 

Clinical skills to empower parents and communities

There were two concurrent sessions: one attended by doctors from the Haemophilia Treatment Centre, and the other attended by community members including factor VIII and XI recipients, caregivers and parents. The doctors’ meeting was shown informative videos and demonstrations on how to administer the newly devised factor VII and XI kit, and discussed the pressing need for trained nurses at local clinics. Dr Jaco Joubert, a haematologist, made an educational presentation to the community members.

The South African Haemophilia Foundation was represented by Mahlomola Sewolane, who gave a brief talk about the role of the organisation in relation to the condition. Meanwhile, procedural training in the simulation laboratory involved doctors and nurses helping participants to learn the procedures by using mannequins and even some volunteers from among the patients.

A medical condition causing serious complications
Haemophilia is a medical condition in which the ability of the blood to clot is severely impaired, even from a slight injury. The condition is typically caused by a hereditary lack of a coagulation factor, most often factor VIII. Usually patients must go through replacement therapy in which concentrates of clotting factor VIII (for haemophilia A) or clotting factor IX (for haemophilia B) are slowly dripped or injected into the vein, to help replace the clotting factor that is missing or low. Patients have to receive this treatment in hospital.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept